Cargando…
Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies
INTRODUCTION: For the maintenance treatment of patients with hereditary hemochromatosis (HH), it is advised to keep the transferrin saturation (TSAT) <70% to prevent formation of non‐transferrin‐bound iron and labile plasma iron. The period of the initial iron depletion may last up to 1 year or l...
Autores principales: | Rombout‐Sestrienkova, Eva, Brandts, Lloyd, Koek, Ger H., van Deursen, Cees Th. B. M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299622/ https://www.ncbi.nlm.nih.gov/pubmed/34897777 http://dx.doi.org/10.1002/jca.21956 |
Ejemplares similares
-
A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis
por: Rombout‐Sestrienkova, Eva, et al.
Publicado: (2020) -
Inflammation can increase hepcidin in HFE‐hereditary hemochromatosis
por: Moris, Wenke, et al.
Publicado: (2021) -
HFE Genotype, Ferritin Levels and Transferrin Saturation in Patients with Suspected Hereditary Hemochromatosis
por: Sandnes, Miriam, et al.
Publicado: (2021) -
Phlebotomy increases cadmium uptake in hemochromatosis.
por: Akesson, A, et al.
Publicado: (2000) -
A farewell to phlebotomy—use of placenta-derived drugs Laennec and Porcine for improving hereditary hemochromatosis without phlebotomy: a case report
por: Hamada, Yuki, et al.
Publicado: (2022)